TAK-915 melittoside Fimasartan was approved for use

Fimasartan was approved for use in South Korea in September 9th

3-benzotriazol-2-yl)-2-hydroxy-5-(2

BrH/c1-22(2)15-9-14-19(16-22)25-20(23)21(24

In vitro studies using human articular chondrocytes have shown S-Adenosyl-L-methionine-induced increases in proteoglycan synthesis and proliferation rates in rabbits

TAK-915 melittoside Fimasartan was approved for useTAK 915 is a potent, selective, brain penetrant and orally active phosphodiesterase 2A (PDE2A) inhibitor with an IC50 of 0. 61 nM. TAK 915 is >4100 fold more selectivity for PDE2A than PDE1A. TAK 915 has the potential for neuropsychiatric and neurodegenerative disorders treatment. Product information CAS Number: 1476727 50 0 Molecular Weight: 458. 36 Formula: C19H18F4N4O5 Chemical Name: N [(1S) 1 [3 fluoro 4 (trifluoromethoxy)phenyl] 2 methoxyethyl] 7